Kimberly R Pechman

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. ncbi Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Research Program, Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Magn Reson Med 68:1266-72. 2012
  2. ncbi Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, WI, USA
    J Neurooncol 105:233-9. 2011

Detail Information

Publications2

  1. ncbi Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Research Program, Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Magn Reson Med 68:1266-72. 2012
    ....
  2. ncbi Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, WI, USA
    J Neurooncol 105:233-9. 2011
    ..Conversely tumor vascularity, as measured with rCBV, was inhibited equally well for all doses used with no clear indication that higher doses are more effective...